Oncology Drug Advisory Committee

Bragar Eagel & Squire, P.C. Is Investigating Inotiv, TG Therapeutics, Allianz, and Outset Medical and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022
Complaint, Outset Media, Review, FDA, Chronic lymphocytic leukemia, Patient, Oncology Drug Advisory Committee, Adult, Fraud, P.C, Therapy, File, SLL, Allianz, GLOBE, Animal welfare, Company, U.S. Securities and Exchange Commission, Follicular lymphoma, ODAC, District court, Seizure, BLA, Animal Welfare Act of 1966, CLL, Food, Douglas v. U.S. District Court ex rel Talk America, Risk, U.S. Department of Commerce Office of Security, LLC, Shanda, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Lymphocytosis, News, TG, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, DOJ, Umbralisib, Online gambling, Renewable energy, Audit, Dietary supplement, Medical device, Envigo, U2

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The complaint is a civil action by DOJ alleging violations of the Animal Welfare Act at the Cumberland, Virginia facility.
  • For more information on the Outset Medical investigation go to: https://bespc.com/cases/OM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Loyalty Ventures, Inotiv, TG Therapeutics, and Allianz and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 25, 2022
Patient, Oncology Drug Advisory Committee, P.C, File, GLOBE, Company, AIR, Food, U.S. Department of Commerce Office of Security, U.S. Department of Justice Office of Legislative Affairs, Atlantic Canada, Regulation of tobacco by the U.S. Food and Drug Administration, Therapy, FDA, Fraud, EBITDA, Allianz, Seizure, BLA, Animal Welfare Act of 1966, LLC, Alliance Data, TG, DOJ, SLL, CLL, Miles (given name), NASDAQ, News, Complaint, Review, Chronic lymphocytic leukemia, Adult, Animal welfare, Follicular lymphoma, U.S. Securities and Exchange Commission, District court, ODAC, Risk, Douglas v. U.S. District Court ex rel Talk America, Shanda, Lymphocytosis, Program, Umbralisib, Motor vehicle, Medical device, Renewable energy, Audit, Dietary supplement, Sobeys, U2, Envigo

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The Company owns and operates the AIR MILES Reward Program, an end-to-end loyalty platform; and BrandLoyalty, a campaign-based loyalty solution for grocers and other high-frequency retailers.
  • On November 5, 2021, Loyalty Ventures became a publicly traded company after its separation from Alliance Data Systems Corporation.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors TG Therapeutics, Inc. - TGTX

Retrieved on: 
Thursday, June 23, 2022
SLL, GLOBE, FDA, Patient, Shanda, Regulation of tobacco by the U.S. Food and Drug Administration, Oncology Drug Advisory Committee, NASDAQ, Chronic lymphocytic leukemia, Follicular lymphoma, Prescription Drug User Fee Act, TG, Food, Company, ODAC, Therapy, Umbralisib, Review, Adult, News, CLL, BLA, High-performance plastics, U2

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (TG Therapeutics or the Company) (NASDAQ: TGTX).

Key Points: 
  • NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (TG Therapeutics or the Company) (NASDAQ: TGTX).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether TG Therapeutics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Is Investigating Inotiv, TG Therapeutics, Singularity Future, and Allianz and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, June 20, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BLA, Mining, DOJ, Allianz, U.S. Securities and Exchange Commission, ODAC, Therapy, GLOBE, Complaint, Hindenburg Research, File, Review, Animal Welfare Act of 1966, U.S. Department of Commerce Office of Security, Douglas v. U.S. District Court ex rel Talk America, Charles Ponzi, Seizure, Follicular lymphoma, District court, NASDAQ, News, SLL, U.S. Department of Justice Office of Legislative Affairs, Shanda, TG, FDA, P.C, LLC, Technology, Chronic lymphocytic leukemia, Umbralisib, Hindenburg, Adult, Patient, Oncology Drug Advisory Committee, CLL, Miner, Risk, Fraud, Lymphocytosis, Company, Animal welfare, Run, KOI, Food, Online gambling, Renewable energy, Audit, Dietary supplement, Medical device, Cryptocurrency, U2, Envigo

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The complaint is a civil action by DOJ alleging violations of the Animal Welfare Act at the Cumberland, Virginia facility.
  • For more information on the Allianz investigation go to: https://bespc.com/cases/ALIZY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors TG Therapeutics, Inc. - TGTX

Retrieved on: 
Tuesday, June 14, 2022
Chronic lymphocytic leukemia, Adult, Follicular lymphoma, Company, Oncology Drug Advisory Committee, Food, News, Prescription Drug User Fee Act, Therapy, FDA, GLOBE, Patient, TG, Review, BLA, NASDAQ, Umbralisib, ODAC, CLL, SLL, Shanda, Regulation of tobacco by the U.S. Food and Drug Administration, High-performance plastics, U2

NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (TG Therapeutics or the Company) (NASDAQ: TGTX).

Key Points: 
  • NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (TG Therapeutics or the Company) (NASDAQ: TGTX).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether TG Therapeutics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Is Investigating Kohl’s, MEI Pharma, and TG Therapeutics and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 14, 2022
Chronic lymphocytic leukemia, Mission statement, Adult, Follicular lymphoma, Company, Oncology Drug Advisory Committee, Food, Lymphocytosis, News, Therapy, FDA, Patient, GLOBE, TG, Review, NYSE, BLA, NASDAQ, Umbralisib, ODAC, CLL, SLL, Shanda, Regulation of tobacco by the U.S. Food and Drug Administration, KSS, Generic drug, Medical device, U2, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Kohl's stock price fell $5.84 per share, or 12.97%, to close at $39.20 per share on May 20, 2022.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • For more information on the TG Therapeutics investigation go to: https://bespc.com/cases/TGTX
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Singularity Future, and TG Therapeutics and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 9, 2022
Miner, Chronic lymphocytic leukemia, Mining, Adult, Follicular lymphoma, Company, Charles Ponzi, Oncology Drug Advisory Committee, Food, Lymphocytosis, Hindenburg, EVP, CEO, News, HuffPost, Medal, RBB, Royal Business Bank, Therapy, FDA, GLOBE, Patient, KOI, TG, Hindenburg Research, Review, BLA, NASDAQ, Alpha, SEC, Umbralisib, ODAC, Run, CLL, SLL, Shanda, Regulation of tobacco by the U.S. Food and Drug Administration, Technology, Online gambling, Audit, Medical device, U2, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • For more information on the TG Therapeutics investigation go to: https://bespc.com/cases/TGTX
    About Bragar Eagel & Squire, P.C.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors TG Therapeutics, Inc. - TGTX

Retrieved on: 
Sunday, June 5, 2022
Chronic lymphocytic leukemia, Adult, Follicular lymphoma, Company, Oncology Drug Advisory Committee, Food, Lymphocytosis, News, Prescription Drug User Fee Act, Therapy, FDA, GLOBE, Patient, TG, Review, BLA, NASDAQ, Umbralisib, ODAC, CLL, SLL, Shanda, Regulation of tobacco by the U.S. Food and Drug Administration, High-performance plastics, U2

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (TG Therapeutics or the Company) (NASDAQ: TGTX).

Key Points: 
  • NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (TG Therapeutics or the Company) (NASDAQ: TGTX).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether TG Therapeutics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, GoodRx, Agrify, and Pegasystems and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 4, 2022
Chronic lymphocytic leukemia, Adult, Follicular lymphoma, Company, Wisconsin circuit courts, Oncology Drug Advisory Committee, Food, Lymphocytosis, News, Letter, The Nuts & Bolts of PBM, Therapy, FDA, GLOBE, Patient, TG, Review, BLA, NASDAQ, Umbralisib, GoodRx, ODAC, CLL, Circuit court, SLL, Shanda, Regulation of tobacco by the U.S. Food and Drug Administration, Private investigator, Medical device, Renewable energy, Audit, U2, Pegasystems, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • On this news, GoodRxs stock fell $2.78, or 25.9%, to close at $7.97 on May 10, 2022, thereby injuring investors.
  • For more information on the Pegasystems investigation go to: https://bespc.com/cases/PEGA
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, May 23, 2022
Follicular lymphoma, Company, Shanda, Oncology Drug Advisory Committee, Regulation of tobacco by the U.S. Food and Drug Administration, Fraud, Food, Chronic lymphocytic leukemia, News, Patient, NASDAQ, Umbralisib, Therapy, Review, Lymphocytosis, Adult, BLA, FDA, GoodRx, The Nuts & Bolts of PBM, ODAC, CLL, SLL, Letter, TG, GLOBE, Pharmaceutical industry, Medical device, Audit, Renewable energy, U2, P.C, Clariant, Coinbase

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • For more information on the TG Therapeutics investigation go to: https://bespc.com/cases/TGTX
    On May 10, 2022, Coinbase reported its first quarter 2022 results.